HEADER TRANSCRIPTION 31-JAN-10 3LMP TITLE CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE TITLE 2 DERIVATIVE MODULATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 234-505; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE OF NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 9 CHAIN: C; COMPND 10 FRAGMENT: UNP RESIDUES 686-700; COMPND 11 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 12 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52, CLASS E BASIC COMPND 13 HELIX-LOOP-HELIX PROTEIN 74, BHLHE74; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1C3, PPARG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SG13009; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE30; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: SYNTHETIC PEPTIDE KEYWDS THREE-LAYERED ALPHA-HELICAL SANDWICH, ACTIVATOR, ALTERNATIVE KEYWDS 2 SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL- KEYWDS 3 BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, KEYWDS 4 TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR Y.MATSUI,H.HANZAWA REVDAT 3 01-NOV-23 3LMP 1 REMARK SEQADV HETSYN REVDAT 2 01-NOV-17 3LMP 1 REMARK REVDAT 1 14-APR-10 3LMP 0 JRNL AUTH A.FURUKAWA,T.ARITA,S.SATOH,K.WAKABAYASHI,S.HAYASHI,Y.MATSUI, JRNL AUTH 2 K.ARAKI,M.KUROHA,J.OHSUMI JRNL TITL DISCOVERY OF A NOVEL SELECTIVE PPARGAMMA MODULATOR FROM JRNL TITL 2 (-)-CERCOSPORAMIDE DERIVATIVES JRNL REF BIOORG.MED.CHEM.LETT. V. 20 2095 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20219371 JRNL DOI 10.1016/J.BMCL.2010.02.073 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1027890.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 21697 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2183 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2170 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2130 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2183 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0050 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 21697 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3195 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 334 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2221 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.34000 REMARK 3 B22 (A**2) : -1.12000 REMARK 3 B33 (A**2) : -2.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.003 REMARK 3 BOND ANGLES (DEGREES) : 0.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.540 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.130 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.820 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.770 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.740 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 43.96 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LMP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057467. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21723 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03800 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.21600 REMARK 200 FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, NASCN, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 295K, VAPOR DIFFUSION, HANGING DROP, PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.98750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 195 REMARK 465 ARG A 196 REMARK 465 GLY A 197 REMARK 465 SER A 198 REMARK 465 HIS A 199 REMARK 465 HIS A 200 REMARK 465 HIS A 201 REMARK 465 HIS A 202 REMARK 465 HIS A 203 REMARK 465 HIS A 204 REMARK 465 GLY A 205 REMARK 465 PRO A 206 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLY C 697 REMARK 465 SER C 698 REMARK 465 PRO C 699 REMARK 465 SER C 700 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 259 6.75 -66.21 REMARK 500 ASP A 462 58.80 -100.83 REMARK 500 HIS C 687 35.88 75.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CEK A 23 DBREF 3LMP A 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 3LMP C 686 700 UNP Q15788 NCOA1_HUMAN 686 700 SEQADV 3LMP MET A 195 UNP P37231 EXPRESSION TAG SEQADV 3LMP ARG A 196 UNP P37231 EXPRESSION TAG SEQADV 3LMP GLY A 197 UNP P37231 EXPRESSION TAG SEQADV 3LMP SER A 198 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 199 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 200 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 201 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 203 UNP P37231 EXPRESSION TAG SEQADV 3LMP HIS A 204 UNP P37231 EXPRESSION TAG SEQADV 3LMP GLY A 205 UNP P37231 EXPRESSION TAG SEQRES 1 A 283 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY PRO GLU SEQRES 2 A 283 SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SEQRES 3 A 283 SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA SEQRES 4 A 283 ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO SEQRES 5 A 283 PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU SEQRES 6 A 283 ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU SEQRES 7 A 283 GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS SEQRES 8 A 283 GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU SEQRES 9 A 283 TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU SEQRES 10 A 283 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU SEQRES 11 A 283 ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP SEQRES 12 A 283 GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG SEQRES 13 A 283 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE SEQRES 14 A 283 MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA SEQRES 15 A 283 LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA SEQRES 16 A 283 VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 17 A 283 VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN SEQRES 18 A 283 ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SEQRES 19 A 283 SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP SEQRES 20 A 283 LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN SEQRES 21 A 283 VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO SEQRES 22 A 283 LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 C 15 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 2 C 15 PRO SER HET CEK A 23 36 HETNAM CEK (9AS)-8-ACETYL-1,7-DIHYDROXY-3-METHOXY-9A-METHYL-N-(1- HETNAM 2 CEK NAPHTHYLMETHYL)-9-OXO-9,9A-DIHYDRODIBENZO[B,D]FURAN-4- HETNAM 3 CEK CARBOXAMIDE HETSYN CEK (9AS)-8-ACETYL-1,7-DIHYDROXY-3-METHOXY-9A-METHYL-N- HETSYN 2 CEK (NAPHTHALEN-1-YLMETHYL)-9-OXO-9,9A-DIHYDRODIBENZO[B, HETSYN 3 CEK D]FURAN-4-CARBOX AMIDE FORMUL 3 CEK C28 H23 N O7 FORMUL 4 HOH *191(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 GLY A 239 1 11 HELIX 3 3 ASP A 251 GLU A 259 1 9 HELIX 4 4 GLU A 276 LYS A 301 1 26 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 LEU A 333 1 24 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 PHE A 360 ALA A 376 1 17 HELIX 9 9 ASP A 380 LEU A 393 1 14 HELIX 10 10 ASN A 402 HIS A 425 1 24 HELIX 11 11 GLN A 430 GLU A 460 1 31 HELIX 12 12 HIS A 466 LYS A 474 1 9 HELIX 13 13 HIS C 687 GLN C 695 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N ILE A 341 O GLY A 346 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 CISPEP 1 LYS A 358 PRO A 359 0 -1.17 SITE 1 AC1 14 HOH A 13 HOH A 174 ILE A 262 LYS A 263 SITE 2 AC1 14 GLY A 284 CYS A 285 PHE A 287 ARG A 288 SITE 3 AC1 14 SER A 289 ILE A 341 SER A 342 LEU A 353 SITE 4 AC1 14 LYS A 367 HOH A 478 CRYST1 38.767 53.975 66.531 90.00 92.37 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025795 0.000000 0.001068 0.00000 SCALE2 0.000000 0.018527 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015043 0.00000